118 related articles for article (PubMed ID: 37568251)
1. Correction to: Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer.
J Natl Cancer Inst; 2023 Nov; 115(11):1431. PubMed ID: 37568251
[No Abstract] [Full Text] [Related]
2. Prognostic Significance of Venous Thromboembolic Events in Disseminated Germ Cell Cancer Patients.
Gonzalez-Billalabeitia E; Castellano D; Sobrevilla N; Guma J; Hervas D; Luengo MI; Aparicio J; Sanchez-Muñoz A; Mellado B; Saenz A; Valverde C; Fernandez A; Margeli M; Duran I; Fernandez S; Sastre J; Ros S; Maroto P; Manneh R; Cerezuela P; Carmona-Bayonas A; Ayala de la Peña F; Luis Aguilar J; Rivera S; García Del Muro X; Germà-Lluch JR;
J Natl Cancer Inst; 2017 Jan; 109(4):. PubMed ID: 28122896
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.
Kier MG; Lauritsen J; Mortensen MS; Bandak M; Andersen KK; Hansen MK; Agerbaek M; Holm NV; Dalton SO; Johansen C; Daugaard G
Eur Urol; 2017 Feb; 71(2):290-298. PubMed ID: 27649970
[TBL] [Abstract][Full Text] [Related]
4. Relation of proliferative activity to survival in patients with advanced germ cell cancer.
Sledge GW; Eble JN; Roth BJ; Wuhrman BP; Fineberg N; Einhorn LH
Cancer Res; 1988 Jul; 48(13):3864-8. PubMed ID: 2837326
[TBL] [Abstract][Full Text] [Related]
5. Germ Cell Cancer and Multiple Relapses: Toxicity and Survival.
Lauritsen J; Kier MG; Mortensen MS; Bandak M; Gupta R; Holm NV; Agerbaek M; Daugaard G
J Clin Oncol; 2015 Oct; 33(28):3116-23. PubMed ID: 26240225
[TBL] [Abstract][Full Text] [Related]
6. Management of germ cell tumors with somatic type malignancy: pathological features, prognostic factors and survival outcomes.
Rice KR; Magers MJ; Beck SD; Cary KC; Einhorn LH; Ulbright TM; Foster RS
J Urol; 2014 Nov; 192(5):1403-9. PubMed ID: 24952240
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.
Einhorn LH; Williams SD; Loehrer PJ; Birch R; Drasga R; Omura G; Greco FA
J Clin Oncol; 1989 Mar; 7(3):387-91. PubMed ID: 2465391
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
9. Current Management of Disseminated Germ Cell Tumors.
Lavoie JM; Kollmannsberger CK
Urol Clin North Am; 2019 Aug; 46(3):377-388. PubMed ID: 31277732
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of disseminated germ cell tumors].
Kimura G; Akimoto M
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1873-90. PubMed ID: 9797810
[TBL] [Abstract][Full Text] [Related]
11. First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice.
Fujiwara M; Tanaka H; Yuasa T; Komai Y; Oguchi T; Fujiwara R; Numao N; Yamamoto S; Fujii Y; Fukui I; Yonese J
Int J Urol; 2021 Sep; 28(9):920-926. PubMed ID: 34028113
[TBL] [Abstract][Full Text] [Related]
12. First-line combination chemotherapy with cisplatin, etoposide and ifosfamide for the treatment of disseminated germ cell cancer: re-evaluation in the granulocyte colony-stimulating factor era.
Tanaka H; Yuasa T; Fujii Y; Sakura M; Urakami S; Yamamoto S; Masuda H; Fukui I; Yonese J
Chemotherapy; 2013; 59(6):441-6. PubMed ID: 25060582
[TBL] [Abstract][Full Text] [Related]
13. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
Nichols CR; Catalano PJ; Crawford ED; Vogelzang NJ; Einhorn LH; Loehrer PJ
J Clin Oncol; 1998 Apr; 16(4):1287-93. PubMed ID: 9552027
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with relapsed or primary refractory germ cell tumors.
Rejlekova K; Mego M; Sycova-Mila Z; Obertova J; Rajec J; Salek T; Mardiak J
Neoplasma; 2009; 56(3):215-23. PubMed ID: 19309224
[TBL] [Abstract][Full Text] [Related]
16. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.
J Clin Oncol; 1997 Feb; 15(2):594-603. PubMed ID: 9053482
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant germ cell tumors.
Daugaard G; Hansen HH; Rørth M
Ann Oncol; 1990; 1(3):195-202. PubMed ID: 1702008
[TBL] [Abstract][Full Text] [Related]
18. [Smoking: a prognostic factor of lung cancer survival].
Kovács G; Barsai A; Szilasi M
Magy Onkol; 2012 Sep; 56(3):187-91. PubMed ID: 23008827
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study.
Hentrich MU; Bower M; Daugaard G; Dieing A; Bickel M; Berretta M; Lesmeister F; Jurinovic V; Stoehr A; Heinzelbecker J; Krznaric I; Dieckmann KP; Necchi A; Maroto Rey P; Rockstroh JK; Brito M; Pfister D; Hoffmann C
Cancer; 2022 Jan; 128(2):260-268. PubMed ID: 34592009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
